HCSGD entry for EP300
1. General information
Official gene symbol | EP300 |
---|---|
Entrez ID | 2033 |
Gene full name | E1A binding protein p300 |
Other gene symbols | KAT3B RSTS2 p300 |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0000122 | Negative regulation of transcription from RNA polymerase II promoter | IDA | biological_process |
GO:0000123 | Histone acetyltransferase complex | IEA | cellular_component |
GO:0000785 | Chromatin | IEA | cellular_component |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | IEA | molecular_function |
GO:0001047 | Core promoter binding | IDA | molecular_function |
GO:0001102 | RNA polymerase II activating transcription factor binding | IPI | molecular_function |
GO:0001666 | Response to hypoxia | IDA | biological_process |
GO:0001756 | Somitogenesis | IEA | biological_process |
GO:0001889 | Liver development | IEA | biological_process |
GO:0001934 | Positive regulation of protein phosphorylation | IEA | biological_process |
GO:0002039 | P53 binding | IEA | molecular_function |
GO:0003677 | DNA binding | IDA | molecular_function |
GO:0003682 | Chromatin binding | IMP | molecular_function |
GO:0003713 | Transcription coactivator activity | IDA | molecular_function |
GO:0003823 | Antigen binding | IEA | molecular_function |
GO:0004402 | Histone acetyltransferase activity | IDA | molecular_function |
GO:0004468 | Lysine N-acetyltransferase activity | IDA | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005634 | Nucleus | IDA | cellular_component |
GO:0005654 | Nucleoplasm | TAS | cellular_component |
GO:0005667 | Transcription factor complex | IEA | cellular_component |
GO:0005730 | Nucleolus | IDA | cellular_component |
GO:0005737 | Cytoplasm | IDA | cellular_component |
GO:0006351 | Transcription, DNA-templated | IEA | biological_process |
GO:0006355 | Regulation of transcription, DNA-templated | IDA | biological_process |
GO:0006915 | Apoptotic process | IMP | biological_process |
GO:0007049 | Cell cycle | IEA | biological_process |
GO:0007219 | Notch signaling pathway | TAS | biological_process |
GO:0007399 | Nervous system development | TAS | biological_process |
GO:0007507 | Heart development | IEA | biological_process |
GO:0007519 | Skeletal muscle tissue development | IEA | biological_process |
GO:0008013 | Beta-catenin binding | IPI | molecular_function |
GO:0008134 | Transcription factor binding | IPI | molecular_function |
GO:0008270 | Zinc ion binding | IEA | molecular_function |
GO:0009749 | Response to glucose | IEA | biological_process |
GO:0009887 | Organ morphogenesis | IEA | biological_process |
GO:0010560 | Positive regulation of glycoprotein biosynthetic process | IEA | biological_process |
GO:0010942 | Positive regulation of cell death | IEA | biological_process |
GO:0016032 | Viral process | IEA | biological_process |
GO:0016407 | Acetyltransferase activity | IMP | molecular_function |
GO:0016746 | Transferase activity, transferring acyl groups | IDA | molecular_function |
GO:0018076 | N-terminal peptidyl-lysine acetylation | IDA | biological_process |
GO:0018393 | Internal peptidyl-lysine acetylation | IDA | biological_process |
GO:0030324 | Lung development | IEA | biological_process |
GO:0031490 | Chromatin DNA binding | IEA | molecular_function |
GO:0032025 | Response to cobalt ion | IEA | biological_process |
GO:0032092 | Positive regulation of protein binding | IEA | biological_process |
GO:0032403 | Protein complex binding | IEA | molecular_function |
GO:0032481 | Positive regulation of type I interferon production | TAS | biological_process |
GO:0032526 | Response to retinoic acid | IEA | biological_process |
GO:0032967 | Positive regulation of collagen biosynthetic process | IEA | biological_process |
GO:0032993 | Protein-DNA complex | IEA | cellular_component |
GO:0033160 | Positive regulation of protein import into nucleus, translocation | IEA | biological_process |
GO:0033613 | Activating transcription factor binding | IPI | molecular_function |
GO:0034612 | Response to tumor necrosis factor | IEA | biological_process |
GO:0035259 | Glucocorticoid receptor binding | IEA | molecular_function |
GO:0042493 | Response to drug | IEA | biological_process |
GO:0042771 | Intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | IDA | biological_process |
GO:0042975 | Peroxisome proliferator activated receptor binding | IEA | molecular_function |
GO:0043388 | Positive regulation of DNA binding | IEA | biological_process |
GO:0043425 | BHLH transcription factor binding | IEA | molecular_function |
GO:0043491 | Protein kinase B signaling | IEA | biological_process |
GO:0043627 | Response to estrogen | IDA | biological_process |
GO:0043923 | Positive regulation by host of viral transcription | IDA | biological_process |
GO:0043967 | Histone H4 acetylation | IMP | biological_process |
GO:0043969 | Histone H2B acetylation | IDA | biological_process |
GO:0045087 | Innate immune response | TAS | biological_process |
GO:0045471 | Response to ethanol | IEA | biological_process |
GO:0045727 | Positive regulation of translation | IEA | biological_process |
GO:0045773 | Positive regulation of axon extension | IEA | biological_process |
GO:0045793 | Positive regulation of cell size | IEA | biological_process |
GO:0045862 | Positive regulation of proteolysis | IEA | biological_process |
GO:0045944 | Positive regulation of transcription from RNA polymerase II promoter | IDA IMP | biological_process |
GO:0046332 | SMAD binding | IEA | molecular_function |
GO:0048565 | Digestive tract development | IEA | biological_process |
GO:0050681 | Androgen receptor binding | IPI | molecular_function |
GO:0050714 | Positive regulation of protein secretion | IEA | biological_process |
GO:0051019 | Mitogen-activated protein kinase binding | IEA | molecular_function |
GO:0051059 | NF-kappaB binding | IEA | molecular_function |
GO:0051091 | Positive regulation of sequence-specific DNA binding transcription factor activity | IDA | biological_process |
GO:0051384 | Response to glucocorticoid | IEA | biological_process |
GO:0051592 | Response to calcium ion | IEA | biological_process |
GO:0060177 | Regulation of angiotensin metabolic process | IEA | biological_process |
GO:0060298 | Positive regulation of sarcomere organization | IEA | biological_process |
GO:0060765 | Regulation of androgen receptor signaling pathway | IDA | biological_process |
GO:0061418 | Regulation of transcription from RNA polymerase II promoter in response to hypoxia | TAS | biological_process |
GO:0065004 | Protein-DNA complex assembly | IEA | biological_process |
GO:0070301 | Cellular response to hydrogen peroxide | IEA | biological_process |
GO:0070542 | Response to fatty acid | IEA | biological_process |
GO:0071407 | Cellular response to organic cyclic compound | IEA | biological_process |
GO:0071456 | Cellular response to hypoxia | TAS | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.0044578283 | 0.9846942137 | 0.1775105900 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.0436148452 |
GSE13712_SHEAR | Up | 0.4367711935 |
GSE13712_STATIC | Down | -0.0004451624 |
GSE19018 | Up | 0.0849735290 |
GSE19899_A1 | Up | 0.6520193462 |
GSE19899_A2 | Up | 0.5278268257 |
PubMed_21979375_A1 | Up | 0.4059391148 |
PubMed_21979375_A2 | Up | 1.8586821277 |
GSE35957 | Up | 0.0113602914 |
GSE36640 | Up | 0.0683780452 |
GSE54402 | Up | 0.2502883993 |
GSE9593 | Up | 0.0117940370 |
GSE43922 | Up | 0.3038224698 |
GSE24585 | Up | 0.3557914004 |
GSE37065 | Up | 0.2030013788 |
GSE28863_A1 | Up | 1.4979453868 |
GSE28863_A2 | Up | 1.2436181457 |
GSE28863_A3 | Up | 0.1950723400 |
GSE28863_A4 | Down | -0.0244027795 |
GSE48662 | Down | -0.2917802436 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-200c-3p | MIMAT0000617 | MIRT003598 | Microarray | Functional MTI (Weak) | 19569050 |
hsa-miR-200b-3p | MIMAT0000318 | MIRT003599 | Microarray | Functional MTI (Weak) | 19569050 |
hsa-miR-429 | MIMAT0001536 | MIRT003600 | Microarray | Functional MTI (Weak) | 19569050 |
hsa-miR-182-5p | MIMAT0000259 | MIRT003601 | Microarray | Functional MTI (Weak) | 19569050 |
hsa-miR-194-5p | MIMAT0000460 | MIRT003603 | Microarray | Functional MTI (Weak) | 19569050 |
hsa-miR-26b-5p | MIMAT0000083 | MIRT003604 | Microarray | Functional MTI (Weak) | 19569050 |
hsa-miR-374a-5p | MIMAT0000727 | MIRT004566 | Microarray | Functional MTI (Weak) | 19569050 |
hsa-miR-150-5p | MIMAT0000451 | MIRT007087 | Luciferase reporter assay | Functional MTI | 23211718 |
hsa-miR-9-5p | MIMAT0000441 | MIRT021346 | Microarray | Functional MTI (Weak) | 17612493 |
hsa-miR-130b-5p | MIMAT0004680 | MIRT038305 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-615-3p | MIMAT0003283 | MIRT039708 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-181d-5p | MIMAT0002821 | MIRT041181 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-193b-3p | MIMAT0002819 | MIRT041490 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-149-5p | MIMAT0000450 | MIRT045469 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-140-5p | MIMAT0000431 | MIRT045823 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-23b-3p | MIMAT0000418 | MIRT046334 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-181b-5p | MIMAT0000257 | MIRT047254 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-30c-5p | MIMAT0000244 | MIRT047948 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-92a-3p | MIMAT0000092 | MIRT049743 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-30a-3p | MIMAT0000088 | MIRT049923 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-25-3p | MIMAT0000081 | MIRT050220 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-let-7b-5p | MIMAT0000063 | MIRT051995 | CLASH | Functional MTI (Weak) | 23622248 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
- mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 17 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
26629991 | It was shown that HN incubation triggered persistent downregulation of deacetylase SIRT1 and upregulation of acetyltransferase p300, leading to sustained hyperacetylation (at K382) and activation of p53, and subsequent p53/p21-mediated senescent "memory |
26629991 | Interestingly, we found that SIRT1 and p300 could regulate each other in response to HN stimulation, suggesting that a delicate balance between acetyltransferases and deacetylases may be particularly important for sustained acetylation and activation of non-histone proteins (such as p53), and eventually the occurrence of "metabolic memory |
25815136 | Epigenetic regulators such as p300, protein inhibitors of activated Stats and H19 help maintain stem cell quiescence |
24488586 | The transcription factors predicted to regulate these changes, Nf-kappaB, Myb, Nkx2-1, Nr5a2, and Ep300, are known to regulate inflammation, differentiation, lipid metabolism, and chromatin remodeling, all of which have previously been implicated in aging |
24458358 | These observations were paralleled by a downregulation of the GCN5-related N-acetyltransferases (GNAT) p300/CBP-associated factor and its isoform 5-alpha general control of amino acid synthesis (GCN5a), determining a relative decrease in total HAT activity |
24218884 | Comparative Q-PCR was utilized to investigate target gene (P66SHC, EP300, HDAC1) expressions respectively in H2O2 treated groups and normal cell groups |
24218884 | CONCLUSION: P66SHC, EP300 and HDAC1 probably play a role in cellular replicative senescence and oxidative-stress inducing premature senescence |
23698071 | Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells |
23698071 | Global assessment of the p300 HAT transcriptome in human melanoma identified functional roles in promoting cell cycle progression, chromatin assembly, and activation of DNA repair pathways through direct transcriptional regulatory mechanisms |
23698071 | Together, our data suggest that p300 HAT activity mediates critical growth regulatory pathways in tumor cells and may serve as a potential therapeutic target for melanoma and other malignancies by promoting cellular responses to DNA damaging agents that are currently ineffective against specific cancers |
23342163 | High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway |
23342163 | Relationship of such alteration with histone acetylase (HAT) p300 was examined |
23342163 | We also found that p300 and SIRT1 regulate each other in such process, as silencing one led to increase of the others' expression |
23342163 | Chemically induced increased SIRT1 activity and p300 knockdown corrected these abnormalities slowing aging-like changes |
23342163 | Data from this study demonstrated that hyperglycemia accelerates aging-like process in the vascular ECs and such process is mediated via downregulation of SIRT1, causing reduction of mitochondrial antioxidant enzyme in a p300 and FOXO1 mediated pathway |
22731250 | The p300 CH3 domain is essential for both the autoacetylation of p300 and transference of the acetyl group to p53 and HDAC1 is a component of several non-p300 complexes that enhance p53 deacetylation, ubiquitination, and proteosomal degradation |
22731250 | HDAC1 can also bind the p300-CH3 domain, regulating p300 acetylation and interfering with p300 mediated p53 acetylation |
22731250 | The importance of this pathway is illustrated by showing complete restoration of p53 acetylation and partial restoration of p300 acetylation by treating SPRR2A expressing cells with HDAC1 siRNA |
22095030 | In addition, ING proteins are thought to interact with and modulate the function of auxiliary members of p53 pathway, such as MDM2, ARF , p300, and p21, indicating their widespread involvement in the regulation and function of this prominent tumor suppressor pathway |
21868306 | METHODS: In primary human fibroblasts, the proteins regulating cell growth in association with E1A NH(2) terminus, including the Rb family proteins, p300/CBP, and p400, were inactivated or interfered |
21868306 | RESULTS: The Inactivation of Rb family proteins alone was not sufficient to rescue ras-induced cell senescence, whereas inactivation of both the Rb proteins and p300/CBP blocked ras-induced senescence of human fibroblasts |
21868306 | CONCLUSION: Rb and p300/CBP binding activities are both required for E1A to bypass ras-induced senescence in human fibroblasts |
20660480 | We propose that PPARgamma is subject to regulation by acetylation and deacetylation via p300 and SIRT1 in cellular senescence |
17898049 | Treatment of E7-expressing cells with interferon ultimately resulted in cellular senescence through a process that is dependent upon acetylation of p53 by p300/CBP at lysine 382 |
17898049 | Cells expressing mutant forms of E6 that are unable to bind p300/CBP or bind p53 failed to block acetylation of p53 at lysine 382 and were sensitive to growth arrest by interferon |
17898049 | This study identifies an important physiological role for E6 binding to p300/CBP in blocking growth arrest of human keratinocytes in the presence of interferon and so contributes to the persistence of HPV-infected cells |
17452980 | Expression of the N-terminal domain of hAda3 that binds p53 but not p300 blocked p14ARF-induced p53 acetylation and protected MECs from senescence |
16516887 | Relocalization occurs concomitantly with interaction with a subset of nuclear proteins, including PCNA, p53 and several regulators of acetylation such as the p300/CBP and PCAF histone acetyltransferases (HATs), as well as the histone deacetylases HDAC1 and hSir2 |
15892717 | Importantly, a promoter-reporter analysis demonstrated that the coactivator p300/CBP switched MITF from a repressor to an activator of DCT transcription |
9467855 | Also, we have previously found that an increase in the level of the down stream target of p53 protein, p21WAF1/SD11/C1P1, is dependent on both p53 and p300 proteins |
9312059 | We show that the DNA binding and transcriptional activity of p53 protein increases with cell age in the absence of any marked increase in the level of p53 protein, and that p21(WAF1) promoter activity in senescent cells is dependent on both p53 and the transcriptional co-activator p300 |
Entries Per Page
Displaying Page of